Quantcast

Latest drug discovery Stories

2014-05-15 23:09:07

The cell-based assays market is rapidly evolving with a large number of developments taking place to increase accuracy and speed, and reduce costs of drug. http://www.marketsandmarkets.com/Market-Reports/cell-based-assays-market-119917269.html (PRWEB) May 15, 2014 The “Cell-Based Assays Market by Product (Reagents & Assay Kits (Cytotoxicity, GPCR), Cell lines, Plate Readers, HCS, HTS, Software & Assay Development Services), Application (Drug Discovery, ADMET), End-user...

2014-05-15 23:07:49

Transparency Market Research published a new report "Global Life Sciences BPO Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" to its report store. Browse full report: http://www.transparencymarketresearch.com/life-sciences-bpo-market.html. Albany, New York (PRWEB) May 15, 2014 According to a new market report published by Transparency Market Research "Life Sciences BPO Market [Contract Research Organizations (Drug Discovery, Pre-Clinical,...

2014-05-15 12:33:45

LONDON, May 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Sample Preparation in Genomics, Proteomics, and Epigenomics: Global Marketshttp://www.reportbuyer.com/pharma_healthcare/diseases/sample_preparation_genomics_proteomics_epigenomics.html STUDY GOALS AND OBJECTIVESThis BCC Research report, Sample Preparation in Genomics, Proteomics, and Epigenomics: Global Markets, provides an overview of the current overall state of the sample preparation...

2014-05-15 12:29:33

LONDON, May 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Global Markets for Orphan Drugshttp://www.reportbuyer.com/pharma_healthcare/drug_discovery/global_markets_orphan_drugs.htmlINTRODUCTIONSTUDY OBJECTIVESThe orphan drug market is one of the fastest-growing segments in the pharmaceutical and biotechnology industry. BCC's goal in conducting this study is to provide an overview of the current and future global market for orphan drugs. The key...

2014-05-15 04:22:26

LONDON and BOSTON, May 15, 2014 /PRNewswire/ -- Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, notes that Fiona Marshall, Heptares' Chief Scientific Officer and co-founder, will give a company presentation at the UBS Global Healthcare Conference [https://www.ubs.com/global/en/investment-bank/key-investor-conferences/americas.html ] in New York City, NY, USA. The presentation will take place at 9:00am EDT on Monday 19 May....

2014-05-14 23:09:18

New Kauffman Foundation paper highlights solutions to speed patients’ access to drugs with therapeutic value for more than one disease. Kansas City, MO (PRWEB) May 14, 2014 For patients with rare medical conditions, the typical 12 to 15 years it takes to bring a new drug to market may be too long to wait. Repurposed drugs – those already approved for a specific condition that can be used to treat another – offer a solution: Because their safety profile is already established, they...

2014-05-14 23:02:07

The new NextGEN™ CRISPR genome engineering tools and services provided by Transposagen are ideal when research and drug discovery applications require clean, high-precision genome editing. Lexington, KY (PRWEB) May 14, 2014 Altering the genome with targeted nucleases is powerful and increasingly necessary for research and drug discovery. The CRISPR-Cas9 system has gained popularity due to its simplicity and high efficiency. While the original CRISPR technology is not owned or...

2014-05-14 12:31:15

LONDON, May 14, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Biopreservation Market (Product Types - Equipment, LIMS, and Media; Applications - Regenerative Medicine, Biobanking, and Drug Discovery) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 -...

2014-05-14 08:29:39

BALLERUP, Denmark, May 14, 2014 /PRNewswire/ -- Sophion Bioscience (sophion.com [http://sophion.com ]), part of Biolin Scientific, has received its first purchase orders for its new high throughput screening platform from leading pharma companies. The Sophion Qube(TM) measures the effect of potential new drug candidates directly on ion channels in living cells. By a unique combination of high quality recordings and high throughput, the Sophion Qube can boost the productivity...

2014-05-13 23:08:34

Major Pharmaceutical Companies Serving in ADDPLAN DF Consortium Providing Early Feedback Dublin, Ireland (PRWEB) May 13, 2014 ICON plc (NASDAQ: ICLR), today announced that Aptiv Solutions, an ICON plc company leading the design and implementation of adaptive trials, has released ADDPLAN® DF 3.0, which incorporates complex statistical methodologies to prevent under and over-estimation of a therapeutic’s maximum target dose (MTD) during Phase I dose escalation trials. Accurate...


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.